Cerrone Gabriele M's Form 4/A amendment
AmendedOKYO Pharma Ltd (OKYO) · filed May 18, 2022
- Accession no.
- 0001493152-22-014299
- Filed
- May 18, 2022
- Trade date
- May 17, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- May 18, 2022
This filing lists 1 non-derivative transaction. Open-market purchases total $96.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cerrone Gabriele MCIK 0001139306 | Director, Officer (Non-Executive Chairman), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | American Depositary Shares | PPurchaseAcquired | +25,000 | $3.87 | +$96,750 | 25,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.